Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

Olayinka O. Ogunleye(Lagos State University), Debashis Basu(Steve Biko Hospital), Debjani Mueller, Jacqueline Sneddon(Healthcare Improvement Scotland), R.A. Seaton(Healthcare Improvement Scotland), Adesola Yinka-Ogunleye(Nigeria Centre for Disease Control), Joshua Wamboga, Nenad Miljković(University of Belgrade), Julius Chacha Mwita(University of Botswana), Godfrey Mutashambara Rwegerera(University of Botswana), Amos Massele(University of Botswana), Patrick Okwen(University of Bamenda), Loveline Lum Niba(University of Bamenda), Melaine Nsaikila(University of Bamenda), Wafaa M. Rashed(Children Cancer Hospital), Mohamed Ali Hussein(Children Cancer Hospital), Rehab Hegazy(National Research Centre), Adefolarin A. Amu(Southern Africa Nazarene University), Baffour Boaten Boahen-Boaten(Southern Africa Nazarene University), Zinhle Matsebula, Prudence Gwebu, Bongani Chirigo, Nongabisa Mkhabela, Tenelisiwe Dlamini, Samuel Sithole, Sandile Malaza, Sikhumbuzo Dlamini, Daniel Kwame Afriyie(37 Military Hospital), George Awuku Asare(University of Ghana), Seth Kwabena Amponsah(University of Ghana), Israel Abebrese Sefah(University of Health and Allied Sciences), Margaret Oluka(University of Nairobi), Anastasia N Guantai(University of Nairobi), Sylvia Opanga(University of Nairobi), Tebello Violet Sarele(University of KwaZulu-Natal), Refeletse Keabetsoe Mafisa, Ibrahim Chikowe(University of Malawi), Felix Khuluza(University of Malawi), Dan Kibuule(University of Namibia), Francis Kalemeera(University of Namibia), Mwangana Mubita(University of Namibia), Joseph Fadare(Ekiti State University), Laurien Sibomana(University of Pittsburgh), Gwendoline Malegwale Ramokgopa(Steve Biko Hospital), Carmen Whyte(Steve Biko Hospital), Tshegofatso Maimela(Steve Biko Hospital), Johannes F.M. Hugo(Steve Biko Hospital), Johanna C. Meyer(Sefako Makgatho Health Sciences University), Natalie Schellack(Sefako Makgatho Health Sciences University), Enos M Rampamba(Sefako Makgatho Health Sciences University), Adel Visser, Abubakr Abdelraouf Alfadl(Qassim University), Elfatih M Malik(University of Khartoum), Oliver Ombeva Malande(Egerton University), Aubrey Chichonyi Kalungia(University of Zambia), Chiluba Mwila(University of Zambia), Trust Zaranyika(University of Zimbabwe), Blessmore V Chaibva(Ministry of Health and Child Welfare), Ioana D. Olaru(London School of Hygiene & Tropical Medicine), Nyasha Masuka, Janney Wale, Lenias Hwenda, Regina Kamoga(Community Health And Information Network), Ruaraidh Hill(University of Liverpool), Corrado Barbui(University of Verona), Tomasz Bochenek(Jagiellonian University), Amanj Kurdi(Hawler Medical University), Stephen Campbell(Manchester Academic Health Science Centre), Antony P. Martin(University of Liverpool), Thuy Nguyen Thi Phuong(Hanoi University of Pharmacy), Binh Nguyen Thanh(Hanoi University of Pharmacy), Brian Godman(Karolinska University Hospital)
Frontiers in Pharmacology
September 11, 2020
Cited by 216Open Access
Full Text

Abstract

BACKGROUND: The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa. OBJECTIVE: Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups. OUR APPROACH: Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel. ONGOING ACTIVITIES: Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality. CONCLUSION: There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.


Related Papers

No related papers found

Powered by citation graph analysis